Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Chemical substance: Busulfan
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Busulfan 2mg tablets
0801010B0AAABAB
|
Busulfan | Busulfan | Malignant Disease and Immunosuppression | 3 |
|
Busilvex 60mg/10ml concentrate for inf ampoules
0801010B0BCAAAE
|
Busilvex | Busulfan | Malignant Disease and Immunosuppression | No data available |
|
Busulfan 25mg capsules
0801010B0AAAFAF
|
Busulfan | Busulfan | Malignant Disease and Immunosuppression | No data available |
|
Busulfan 2mg/5ml oral liquid
0801010B0AAADAD
|
Busulfan | Busulfan | Malignant Disease and Immunosuppression | No data available |
|
Busulfan 60mg/10ml solution for infusion ampoules
0801010B0AAAEAE
|
Busulfan | Busulfan | Malignant Disease and Immunosuppression | No data available |
|
Busulfan 60mg/10ml solution for infusion vials
0801010B0AAAGAG
|
Busulfan | Busulfan | Malignant Disease and Immunosuppression | No data available |
|
Myleran 2mg tablets
0801010B0BBABAB
|
Myleran | Busulfan | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.